The American Pain Society is pleased to announce the 2nd annual Conference on Analgesic Trials, chaired and moderated by Neil Singla, MD. This event is coming up this May 17 as part of APS’ Annual Scientific Meeting in Pittsburgh.
APS-CAT is a full-day conference focused on optimizing the design and conduct of analgesic clinical trials. APS-CAT 2016 had 200 pain research professionals in attendance and featured expert presentations as well as Q & A with an eight-member panel. Audience feedback was overwhelmingly positive.
Register here.
The goals of this conference are as follows:
- Gather world-renowned experts in clinical trials to convey and analyze current best practices.
- Disseminate the latest scientific and regulatory developments in topics of interest to the analgesic research industry.
- Discuss experimental methods that increase analgesic trial assay sensitivity.
- Involve audience members in dialogue with thought leaders in the field from regulatory bodies, industry, and academia.
- Convene at a familiar venue before the APS Annual Scientific Meeting to facilitate networking and future collaboration.
Presenters include:
Sharon Hertz, MD
Director, FDA Division of Anesthesia, Analgesia, and Addiction Products
Neil Singla, MD
Chief Scientific Officer, Lotus Clinical Research
Nathaniel Katz, MD
President, Analgesic Solutions
Laurie Burke, MD
Founder, LORA Group
Former Director, FDA Study Endpoints and Labeling Development (SEALD) Team
Lars Arendt-Nielsen, Dr. Med., PhD
Center for Sensory-Motor Interaction (SMI)
Department of Health Science and Technology, School of Medicine, Aalborg University
Lee Simon, MD
Principal, SDG, LLC
Former Director, FDA Division of Analgesic, Anti-inflammatory and Ophthalmologic Drug Products
Roy Freeman, MD
Professor of Neurology, Harvard Medical School
Director, Center for Autonomic and Peripheral Nerve Disorders, Beth Israel Deaconess Medical Center
For questions or comments, please contact Clinical Trials SIG Chair Neil Singla, MD.
